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A three-dimensional model for the carcinoembryonic antigen (CEA) has been conslructcd by knowledge-based computer modclling. Each of the 
seven cxtraccllular dolnains of CEA are expected to have immunoglobulin folds. The N-terminal domnin of CEA was modcllcd using the first 
domain of the recently solved NMR structure of rat CD?, as well as the first domain of the X-ray crystal structure of human CD4 and an 
immunoglobulin variable domain REI as templates. The remaining domains were modelled from the first and second omains ofCD4 and REI. 
Link conformations between the domains were taken from the elbow region of antibodies, A possible packing model between each of the seven 
domains is proposed. Each residue of the model is labelled as to its suitability for site-directed mutagenesis. 
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1. 1NTRODUCTION 
Carcinoembryonic antigen (CEA), a highly glycosyl- 
ated cell surface protein of molecular mass about 
180,000 [I], is a widely distributed tumour marker (for 
recent reviews ee [2,3]). Although it is expressed inhigh 
proportions on a variety of human tumours, notably of 
the colon but also of the breast and lung [4], studies also 
reveal the presence of CEA in normal tissues [5]. Thus 
the distribution and possibly the functional role of CEA 
is complex. Nevertheless monoclonal antibodies 
(Mab’s) against CEA have been used successfully for 
redioimmuno-localization f tumors [6-S]. There is now 
a substantial panel of Mab’s to CEA and an attempt has 
been made to place them into non-interacting roups 
[9]. However, little progress has been made towards 
mapping the exact locations of these Mab’s to the sur- 
face of CEA. A carefully constructed epitope map 
should help to probe the function(s) and help in the 
search for Mab’s with greater binding affinity to this 
important umour marker. 
The primary structure of CEA has been obtained 
from the gene sequence [IO]. The mature CEA (starting 
at Lys) consists of 668 amino acids, with the first 643 
being extracellular. The extracellular region consists of 
seven domains, each having sequence similarity with 
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immunoglobulin (Tg) domains, thus CEA is a member 
of the Ig superfamily [l 11. 
At present, there is no crystal structure for CEA that 
could guide structure/function studies, such as site-di- 
rected mutagenesis, however, the sequence relationship 
with the immunoglobulins uggests that the complete 
extracellular region can be modelled with some confi- 
dence from Jg folds whose structures are known from 
X-ray and NMR analysis. There are now a number of 
fully determined lg folds from the Fab fragments of 
antibodies, and recently for two cell surface antigens, 
the first two domains of human CD4 (X-ray) [13], and 
the first domain of rat CD2 (NMR) [14]. In this paper 
we report the prediction for each of the seven extracellu- 
lat domains based on multiple sequence alignments [IS], 
and a knowledge-based approach for fragment fitting 
[ 16-191. As the links between each of the seven domains 
show some similarity to the links between the variable 
and constant domains of Ig folds from Fab fragments 
we also suggest how these seven domains are packed 
together. 
2. EXPERIMENTAL 
2. I. Aligttawnr of CEA wi~lr itrrr,turro~lohulltt.s 
The basic structure of an Ig domain is a tertiary fold consisting ol 
a stacked pair of!-sheets. In the known s!ructure of the Ig constant 
domains (C), there arc seven component p-strands (Ictlercd A-G), 
with strands .A, B, E and D lying antiparallel in one sheet and strands 
G, F and C being antiparallel in the other. The variable domains(V) 
have an analogous fold but between strands C and D there arc extra 
strands, C and C”. The C” svnnd i-. very short. In all antibody do- 
mains of these types there is u conserv& disuiphido bridge bttwccn 
strands B and F, however, for some members of the lg superfarldly. 
e.g. CD?, this is not always the case [I I]. A third type of 1s domain, 
207 
Volume 301, number 2 
l-109 
CEA(N1 
CDZtll 
CD4(11 
REX 
BURIED 
STRAND 
. . . . 
, r SUll Urfdgo 7 
KLTIE-3TPFN"AEGKE"L~"B--NLPPKLFGY9HYKGIKVDQNR9IIGWIGTQPATPCPA-Y9EREIIYP ------NASLLIQNIIQNDTFYTLltktSDLVNEE~TO-QFAVYPE 
------SGTIM~HCINLNIPNFQMTDDIDEVRHERG-----9TLV~FKR-~KPFLK ----SCAFEILA------NGDLK~~LT~DSG~VTWSTL 
------KKWLGKKGDTVCLTCT--ASQKK9IQFHWKN9 ----NQIKILGN~--GSFLTKGPSKLND~9RR9LWDQGNFPLIIKNLKI~SDTYICE~----D---QKE-EVQLLVF 
Q~T~3P-99L9ASV~RVTITCQ--ASQDIIKYLNHYWTPGKAPKLLIYE-A----SNLPAC-VPSRF9GSOSC ---TDYTFTISSLQPEDIATYTTYCQQYQSLPY---TFGQGTKLQIT 
t * "1 "f I. . et. t t *t* I l 
110-202 
x:' 
CD4(1) 
REI 
BURIED 
STRRND 
. . . 
, 
LPKPSIS9NNSKPVEDKDAVAFTCEPETQDATYLWWVNNQ9LPV9P LSNCN---------------------------ATLTLFNYG 
----GLTANSDTtiLLQGQ9LTLTLE9PPG99PSVGCR9P -------RGKKxQGG--------------------------- KTLSVSQLELQDSGTWTCTVL9NQ---KKVQF-KIDIVVX 
--------KK~KKGDTVELTCTASQKKSIGFll~K~S -------N@SKILCNQGSFLTKCPSK~D~SMSLWDQGNFPLII~LKI~D9DTYICEVE-------DQKE-PV4LL~ 
DIQK~SP-SSLSASVGDRVTITEQASPDTfKYLNWY~QTPG---KAPKLLIYS-A--SNLQAG-VPBRFS9G--- TDYTFTISSL4PBDIATYYCQQYQSLP---YTFGQGTKLQIT 
l * . l l t * * t *t * l * * .* 
-----A----- _-_&_ --C-s- ..-C'- C" ___D-_ ---p- -_F-__ __--G____ 
203-287 
CEA(It3) 
CD4(2) 
CDQ(1) 
REI 
WAIED 
STRAND 
. . 
PDAPTI9;-LNT9YA9SGE~LNL9CliAMNPPAQY9WFVN -----GTFQQST---------------------------QE~FIPNI~NLGSYTC4AnN;DTGLNRrP 
----GLTANSDTHLLQCPSLTLTLESPPGSSPSVQCRSP ----ROKNIqGG---------------------------KTL3V3QLSLQDSGT~T~NQ----KKVQF-KIDI~ 
--------KKWLGKKGDTVELl'CTA9P ----NQIKI~NQG9FLTKOP9KLND~S~LWDQGWFPLIIKNLKI~9DTYICE~--------DQKE-EVQLL~ 
DIQMTQSP-SS~ASVGDATITC~QDIIKY~WY49TSG9GSG ---TDYTFTIS9MPEDIATYYGQQYQSLPY----TFGQGl'KLQIT 
** I *.* t. t tt * l * t It 
-----A-~--- ---S__ -_C-_- __C'__ C" ---D-w ---Em_ __-p-m- ----G---m 
FEBS LETTERS April 1992 
Fig. I. Scqucncc alignment of the first three domains of CEA with the templates used for modelling. Every tenth residue of CEA is marked by 
a dot. Identical residues are highlighted, gaps are denoted by dashes, In the rowdenoted BURIEU asterisks indicate those residues that arc greater 
than or equal lo 90% buried in all templates. These percentages were calculated by a local program, TEMPLATE, which measures the solvent 
accessibility ofeach residue relative IO an extended Gly-X-Gly chain. STRAND drnotcs the uvcragcd secondary structurcclemcnts for the templates; 
strands arc labcllcd A to G for each fold. Conserved hydrophobic residues and key residues, such as the conserved salt bridge in the N-terminal 
domains (not CD?), help to unchor lhe alignment in place. For the C2 domains, A and B repeats. the C” and D strands are predicted to be missing 
relative to a full V domain. 
termed C2. is not found in antibodies but occurs in other members of 
the lg superfamily [I I]. Thcsc domuins have a greater sequence simi- 
lurity and structural topology to V domains bui arc of similar length, 
and even shorter, in sequence to that of C domains. The rcccnt X-ray 
crystal structure of a C2 domain, the second domain of human CD4 
[ 131, shows that in this CZ domain the C” and D strands are missing 
compurcd IO a V domain. 
The first slcp in prediction by homology is to establish the most 
suitable parent proteins of known structure on which to base the 
modelling [161. The N-terminal Ig domain has been prcdictcd to bc V 
type [I I]. This is followed by three gene duplication repeats, each of 
which consisls of two CZlike domains, labelled ‘type A’ and ‘-B’ [ 121. 
Table I gives the results of scqucnce alignments of each of these 
domains with known (X-ray and KMR) Ig folds using the ALIGN 
program 1201. The analysis agrees with the predictions made above and 
also identifies the best templates from which to build each domain. 
The tcmplatcs chosen to build the N-domain were from the crystal 
coordinates of REI (Bencc-Jones dimer VL kappa1 [?I]. CW(domuin 
I)and rhc NMR coordinates from CD2(domaia 1). The only example 
of a fully chnractcrizcd C2 domain is from thr crystal coordinates of 
the second domain of CD4. thus this was the main tcmplale used to 
model the C2 repeats. Howcvcr. the C2 domain from CD4 does not 
have the conserved isulphide link so the variable domains ofCD4( I) 
and REI were also included as lemplatcs. 
Automatic sequence alignments uch as those reported in Table I 
do help to establish the particular class to which each domain belongs, 
However, refined alignment* still require ma.,ual intcrvcntion. The 
best possible alignment for the N-terminal domain of CEA against 
each of the V templates and for the first repeat against its templates 
is shown in Fig. I. Points considered whilst aligning the sequences 
were: (i) keep the key markers of the fold aligned, such as the con- 
scrvcd Trp in the C strand, conserved salt bridges and disulphidc links; 
(ii) keep the conserved hydrophobic ore of each fold; (iii) maintain 
the&strand structure, i.e. all insertions and deletions hould bc in the 
loop regions; and (iv) where possible the above points should be 
con&lent wilh an alignment between lhe sequence to bc modelled and 
other close members of that family (see- Fig. 2). 
2.2. .WoUlitry rite rtzuitt rhuitr 
The alignment of Fig. I defined ihc conscrvcd b-strand framework 
208 
for the tcmplatcs used. To obtain a structural equivalcncing for the 
residues of the Dumcwork the relevant emplates were first superim- 
posed [171. The average strand lengths and their positions were then 
assigned by visual inspection, Main-chain aloms for different strands 
from different emplates. dcpcnding on the sequence correspondence 
with CEA, were used as indicated in Table Il. 
The next siep is to obtuin a model ror the main chain conformation 
Tuble I 
Sequence comparisons of CEA domains N. IA and IB with alher 
Ig-rolds 
CD2 CD4 CD4 IREI 3FAB 3FAB 
(RI) (HI) 0-w W) ww w-1 
CEA(N) 3.11 2.98 0.41 4.09 3.32 0.77 
CEA(IA) 2.45 2.24 2.28 4.53 2.81 2.97 
CEA(IB) 3.85 2.40 4.19 2.49 2.74 3.75 
---.. 
The tublc gives Ihe number ofslandard deviations between the align- 
menu score and the mean for 500 randomized sequences. The program 
ALIGN [20] was used with a gap pcnully of 6, a weight of 6 and the 
MD250 matrix. Highlighted scores indicate the templates used in the 
modclling process. CDZ(Rl). rat CD2 first domain, V; CD4(HI). 
human CD4 iirst domain, V; CD4(H2), human CD4 second omain, 
C?; IREI( Bcnce-Jones immunoglobulin, V; 3FAB(VH), human 
immunoglobulin (NW) heavy chain, V; and 3FAB(LH), human im- 
munoglobulin (New) light chain, V [37]. The table helps to identify 
domains belonging to a particular class. for example CEA(N) scores 
badly against CD4(H2) (a C2 domain) but well against most V do- 
mains. This table also helped to select he templates from which to 
model each domain, The highest scores were not necessarily taken to 
represent the best templates, for example CEA(II3) scores reasonably 
well with both CD2(RI) and CDI(H1) with CD2(RI) being slightly 
higher. However. CD?(H I) W;LS used as a template for CEA(IB) be- 
cause it has a conserved isulphidc link between the B and F strands 
of the Ig fold and CDZ(HI) does not. As CEA(IB) also has the 
conscrvcd isulphidc il makes the modclling process more accurate to 
choose the CD4(H I) template. 
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Fig, 2. Sequcncc nlignmcms Ibr lhc N-lurmintil domain oTCEA. the repealing A. B units of CEA and olhcr members of Ihe CEA family. NCA. 
human non-specific rossreacting anligcn [43]; TM-CEA. IIUII~UI lransmembranc CEA [44]: W272. H new spccics of human NCA [45]. In general 
there arc more sequcncc diffcrrnces in the loop regions (bclwccn strunds). Thcrc arc. howcver. no inscriions or dclctionscvcn bclwccn various farnil) 
members suggcning slrong evolutionary pressure LO mainlain. certainly a similar molecular lopology for each molecule, bul also sinrilarhy in prolcin 
limclion. Many of the polcnlial N-glycosyloiion siies. undcrlincd. are also conscrvcd, CODE rcfcrs 10 ihc individual r&dues of CEA as to their 
suilability for she-direclcd mutagenesis cxperimcnls (see 1~x1): +.cxpos& -, 90-IO@% buried: +. semi-buried 60-908; s, a prolinc or glycinc residue. 
residues csscnlial ’or the rolds stubility; c, prcdicied to bt covurcd by curbohydrau: i. inierhcc rc%iduc htwecn domains: n, Am-linked glycosylation 
silt. Mosl carbohydrate-covered csiducs arc hydrophobic and lhcsc arc highly conserved both within repeats and within family members. Predicted 
inicrfacc residues arc also well conscrvcd, Tar cxumplc the salt bridges rrsiducs K( I 12) 10 D( 153) and D(204) 10 R(276) (ahho@ not lasl B repcal). 
The first slill bridpc is also conscrvcd at lhc imcrl:dcc of VL-lo-CL domains in 3FAB (immunoglobulin (New)) [42]. 
of the regions, mainly loops bctwccn P-strands, thul connect lhc con- 
served sections of the multiple tcmplaic. One standard approach 
[ 18,191 LO model a conncclion ol’ tt rcsiduus thai spans lixcd regions. 
in lhis case usually @irands. is to search through a dalabnsc 01’ the 
known proteins For a fragmcnl of the uppropriaw numhcr of residues 
lhat roughly span the connection. A modified version of this approlich 
was used and candidalc t’ragmcnts wcrc oblaincd from a data base 
consisting of the atomic coordinates for all ihc Ig folds charucteriscd 
by X-ray crystallography. The daiubiisc was compilsd from twclvc 
Fab fragments, Brookhaven co&s: 3FAB. 4FAB. ZMCP. ZFB4, 
3HFM, 3MCG, IMCW, IHFL, 1REI. ?.FBJ. ZRHE. and 2102. and 
iwo cell surl’ace molecules, ZHLA (ihc Ig Folds orclass II HLA) and 
CD4. plus the NMR coordinalcs oT CD?. Thus by using dill-crcnl 
p-srands rrom the ~cmplaics and diffcrcm I’ragmrnls from an Ig dalu- 
base (see Table II) the best IYamcwork for each fold wus built. 
2.3. Corxphfit~~ ouch clottmitt 
The CEA side chains were placed on the model und their oricnta- 
tions sclcclcd by ihe rollowing criteria: 
(i) the conformation or the equivalent residue in lhc iramcwork was 
used iT ;hcrc was an identicul residue in CEA: 
(ii) for conserved substhutions the CEA side chain was posiiionrd 
in an analogous localion to the side chain of the framework [23]; 
(iii) l’or non.conscrved substiiuiions. the CEA si& ciluilr was sci la 
the mosl commonly ohscrvcd conrormalion [24]; 
(iv) finally, visual inspection removed any serious teric clashes by 
sc!ecling an ahcrnalc, allowed side chain conform&on. 
Each domain was energy-minimized using the CHARMM program 
[25] with d&u11 values as incorporated into QUANTA in the 
POLYGEN softwiirc. Initially 25 sleps of siecpcst descent were per- 
rorrncd 10 rcmovc lhc major stcric clashes. This was followed by SO0 
slcps oradopled basis Newton-Raphson minimizaiion. The minimiza- 
tion scr\‘cs IO ohlain good pptidc geometry and to remove all stcric 
claslws. A stable negative nergy was obtained for each domain. How- 
cvcr. a low cncrgy is not necessarily an indialion lhdl a model is 
correct 1261. Each model was iherul’orc tested by a program called 
POL_DIAGNOSTICS_88 [?7] that compares kcychnractcristicquan- 
tilics of a model with those observed for a wide rnngc of proteins in 
ihu Brookhavcn database. such as the ratio orhydrophobicand hydro- 
philic residues exposed on the surface of the protein compared with 
those or the core. All domains pass& cash lest se1 by the program. 
Comparison or the scquenccs bctwccn domains how two types of 
similar linkers: type I between the N-terminal V domain and the firs1 
IA repeat and between B-to-A repcats: type II bctwccn all A-to-B 
repeals. Fig. 3 shows an alipnmcnl ofall thcsc CEA linker regions with 
the elbow regions buiwccn V and C domains oT an Fab fragment. 
Thcrc are some scqucncc similarhics uch as conserved prolincs and 
hydrophilic residues. As a tentative suggestion WC modclled the linker 
conformations hnscd on the e!bow join1 ronformation from this ;tn\i- 
body. The resulting packing arrangcmcnt bctwccn each domain is 
supporlcd by the l’aci that many orihc predicted inicrfacc rcsiducs arc 
conserved within rcp+xts including a conscrvcd salt bridge at ali but 
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Fig. 3. Sequence alignment of all the linker regions of CEA with that 
of an antibody elbow region from 3FAB (immunoglobulin (New)) 
[42]. Buried residues in the/?-strands across the inurface of the VL and 
CL domains of 3FAB arc indicated by asterisks. 
one interface. These salt bridges lie between the linking region and the 
F-G loop oi the following domain (see Fig, 2). A salt bridge is also 
conserved in the elbow region of many antibodies. However it should 
bc noted that other packinp arrangements are possible and that con. 
lirmation can only come frxL1 an X-ray crystal structure of two or 
more domains of CEA or possibly by extensive Mab epitope mapping 
as recently described for a related Ig superfamily prowin ICAM-I 
(intercellular adhesion molecule- I) [28]. 
The complete model for the extracellular portion of CEA was then 
subjected to the same energy minimization and testing protocol as 
described above for the individual domains. The model passed all 
empirical tests et by program POL_DIAGNOSTICS_88, 
2.5. Placettrenr of N-linked ofigosaccharkies 
The high molecular weight of CEA. compared with that for the 
molecular weight culculated from just the unaglycosylated prolein. 
indicates that most if not all potential N-linked glycosylntion sites are 
occupied [2,3]. 
There are now a few X-ray crystal structures for which coordinates 
have been deposited in the Brookhaven database and that have N- 
linked carbohydrates. for example hemagglutinin [29], and an Fc anti- 
body fragment [30]. Both the above examples show lhal the common 
core carbohydrate covers hydrophobic residues on the surface of the 
protein. The single carbohydrate site on the Fc frngment is more 
relevant o the model for CEA as it is located on the D-E loop of an 
Ig (C) domain and covers hydrophobic residues on lhe B and E 
strands. Clipping this sugar out from the Fc fragment and placing it 
onto the CEA mode! at the first potential N-linked glycosylation site, 
also on a D-E loop on the N-terminal V domain, without adjusting 
any of the torsional parameters of the system shows that this sugar 
can also cover nearby hydrophobic residues: in fact, the equivalent 
hydrophobic residues as found in Fc, those on the B and E strands. 
These hydrophobic residues would normally point OUL into solvent. 
Fig. 2 shows that these hydrophobic residues are conserved for other 
members of the CEA family. The remaining polential N-linked glyco- 
sylation sites were linked to this same sugar frngmcnt and the free 
rotating bonds of the Asn and Asn-sugar complex were adjusted to 
cover nearby, exposed, hydrophobic residues. Because of the large 
number of potentiol glycosylation sites, the abilhy to judge which 
hydrophobic residues are covered by which sugars oon becomes dif- 
ficult. However. Fig. 2 indicates which of the normally exposed rcsi- 
dues, mostly hydrophobic, are predicled to be covered by sugars. The 
prediction does assume that most carbohydrates cover the surface of 
the protein like a net as found for the Fc fragment, however. carbohy- 
drates can also point directly away from the surface of the protein as 
found in the X-ray crystal structure of,bovinc pancreatic DNAse I [31]. 
Nevertheless hydrophobics close to carbohydrate sites should receive 
some cover. This exercise. although not particularly accurate. does 
indicate that there is only one region that carbohydrates do not cover 
completely and that is the CFG face @strands C’, C”, C, F, and G), 
see Fig. 5, of the N-terminal V domain, 
2.6. The rrartsmcmbrane regbr 
There has been some speculation as to whether the string of hydro- 
phobic residues nt the C-terminus of CEA is a transmcmbranc region 
[2,3]. There is a pattern of Gly in this region, every fifth residue, that 
is similar to that for the transmembrane r gion of the alpha and beta 
chains of HLA class II proteins. Fig. 4 shows a helical wheel for the 
transmembrane r gions ofthc alpha [32] and beta [33] chains ofa class 
!I molecule, DRl, and the putative transmcmbrane r gion of CEA. 
All Gly residues arc located on the same side of the helix. Class II is 
strongly predicted to be a hetcrodimer on the cell surface [34] and the 
pattern of Gly residues is expected to aid a close association of the 
transmembrane r gions [35]. This implies that CEA could also be a 
dimer on ihc cell surface. There is also experimental evidence for CEA 
existing as a homodimer from SDS-polyacrylamide g l elecirophoresis 
and cross-linking experiments [36], 
Tuble II 
b-strands and loop fragments used in CEA model building 
Domain Res. range Tcmplatc Fragment 
CEA(N) I-4 
5-8 
9-20 
21-23 
2435 
3U2 
43-48 
49-52 
53-58 
59-63 
64-68 
69-70 
71-7s 
76-92 
93-98 
99-1OG 
LINK 1 107-I 12 
CEA(IA) 113-132 
133-144 
143-148 
149-155 
156-166 
167-181 
182-185 
186-190 
191-199 
LlNK 2 200-20s 
CEA(IB) 206-209 
210-21 I 
2 I?-224 
225-237 
238-243 
244-245 
246-25 I 
252-265 
266-270 
271-275 
276-284 
LINK 3 285-290 
REI 
CD2( I) 
CD2(1) 
CD4( I) 
CD4(1) 
REI 
CD4(1) 
CD2( 1) 
CD4( I) 
CD2(1) 
CD?(I) 
CD4(2) 
CD4( I) 
REI 
CD4(2) 
CD4( 1) 
CD4(2) 
CD4(2) 
CD4(2) 
CD4(2) 
CD4(1) 
REI 
CD4(2) 
CD4( I) 
CD4(2) 
CD4(2) 
2HLA(A) 
3MCG( 1) 
SFAB(H) 
ZMCP(L) 
?HFL(H) 
3FAB(L) 
2HFL(L) 
?HFL(L) 
3FAB(L) 
3HFM(H) 
I FBJ(L) 
lMCW(ivI) 
3FAB(L) 
The table shows the templates and fragments used for the first three 
domains only. The column headed Templutc indicates from which 
template protein the /3-strands were taken and the column headed 
Fragment he proleins from which loops that join theb.strands were 
taken, Selection criteria depended not jusl on sequence compatibility 
with CEA but also on good peptidc geometry belween joining regions 
and the minimization of srcric lashes between atoms. A local program 
wus used to select he correct sections of Templates and Fragments 
and join them together [22]. The remaining A and B repeats plus 
linkers were generated by simple relation and trans!a!ion of these 
building blocks to produzc a rod-shaped molecule. 
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A 
Fig. 4. Helical wheel diagrams for the transmcmbrane r gions of (A) CEA, (II) HLA class II, DR I u and (C) HLA class II, DRl p. All Gly residues 
are on one side of the helix, suggesting close packing between a and B chains of class II, a known hcterodimer. The implication is that CEA may 
have the potential to form homodimers or interact with a second molcculc on the same cell, 
3. DISCUWON AND CONCLLJSION 
Although the Ig domain-like structure of CEA has 
been established by others [11,12], an accurate align- 
ment ofCEA to structural templates and the subsequent 
construction of a full three-dimensional model (see Fig. 
5) has hitherto not been attempted. This approach has 
several advantages over simpler alignments. Residues 
along the sequence can be predicted with more confi- 
dence as to whether they are exposed, part of the con- 
served core of an Ig fold, or buried at the interface 
between domains. This information is of importance in 
guiding the construction of site-directed mutants to 
CEA in order to map Mab epitopes and ultimately the 
function(s) of CEA. 
Fig. 2 shows the relative degree of exposure for each 
of the residues, Several classes are used: 
(i) residues that are 90-1008 buried forming the con- 
served cores of the folds or residues buried at the pre- 
dicted domain-domain interfaces. Such residues would 
not be changed in probing structure/function activities 
for CEA as they are essential for the correct folding and 
packing of the domains; 
(ii) residues that are partially buried, 60-90%. Such 
residues may be changed but care should be taken to not 
change too many at once or to make non-conservative 
changes, e.g. the conserved salt bridge that is partially 
buried in the N-terminal domain; 
(iii) residues that are covered by an adjacent sugar 
site. These residues are exposed on the un-glycosylated 
protein and tend to be hydrophobic. Mutations to these 
residues may indirectly alter functional activity by a!ter- 
ing sugar conformation; 
(iv) residues that are essentially exposed on the sur- 
face and can be changed quite freely. 
Site-directed mutational studies have not been carried 
out on CEA. However, one mutation study has been 
carried out for a closely related cell surface molecule 
NCA [37]. This molecule, although only consisting of 
one internal repeat, is closely homologous to CEA. The 
alignment of the first three domains of CEA and NCA 
are shown in Fig .2. The mutants for NCA lie in a region 
corresponding to the exposed E-F loop at the base of 
the N-terminal domain in which a number of sequence 
substitutions are found relative to CEA. 
A second region that shows differences in sequence 
between CEA and other members of its family, as well 
as between repeats, is in the F-G loop of each fold. 
These loops are also exposed but on the opposite side 
of tt,: molecule to the E-F loops. Therefore this sug- 
gests that monoclonal antibodies raised to the F-G 
loops should fall into different groups from the antibod- 
ies raised to the E-F loops. 
Due to the large number of potential glycosylation 
sites, the amount of exposed protein is expected to be 
relatively small. If indeed CEA is expressed as a homod- 
imer on the cell surface (section 2.6) or associates with 
a second cell surface molecule on the same cell, as for 
example a collagen receptor [38], then even less protein 
would be exposed. This indicates that many of the mon- 
oclonals raised against CEA probably interact, at least 
in Tart, with the sugars. Other than the loops described 
above few other bare protein sites can be identified from 
the model as being sites for antibody attachment. The 
most obvious choice would be from the very top of the 
first domain, in the loops equivalent to the CDR loops 
of an antibody, and the CFG face of the N-terminal 
domain. 
Some of the sugars could mediate protein-protein 
interactions. For example the first highly conserved, 
putative glycosylation site (see Fig. 2) is analogous in 
position to the carbohydrate in Fc fragments (section 
2.5). This sugar mediates CH2-to-CH2 interactions 
across the dimer interface [30]. 
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F-G Loop 
& F-G Loop 
CELL 
1 3 3 3 
w 
c!.C’ Loop 
Loop 
Type I Linker 
/ 
2s, 
Fig. 5. A ribbon diagram of the fit-z three domains of CEA showing 
the postulated packing arrangcmcnt. The complete molcculc. due to 
rotation and translation of the A and I3 rcpcats, would bc rod-like in 
appearance The CFG fxc of each domain is sbadcd. (This includes 
the C’strand for V.) These CFG faces ulternale in orientation, approx. 
180°, about the central axis of the molecule. This sramc alternation al 
CFG faces is found for VL-to.VH packing gcomctries in antibodies 
but also in other ccl1 surface antigens uch as CD4 [I31 and ICAIM-I 
[28]. Asn-linked carbohydrate positions are shown as solid knobs. In 
general the CFG faces are less well covcrcd by carbohydrates than the 
AB( faces; this is particularly noticcablc for the N-terminal do. 
main. A few of the loops arc labcllcd. Particularly exposed and varia- 
ble loops (see Fig. 2) are the E-F and the F-G loops, respectively. 
These loops are predicted to bc on alternate sides of the molcculc. The 
BSurc was produced by the aid of a plotting program called RIBBON 
[461. 
Fig. 6. A highly schematic diagram for how CEA chains, shown as 
oblong boxes, may intcmct o form both homodimers on the same ccl1 
and homotypic interactions between cells. Squiggly lines indicate the 
transmcn~brane region of etch chain, Ovals represent some of the 
curbohydrutcs that would bc truppcd at the intcrfuce between chains 
ofcach dimcr pair. The shaded boxes rcprcscnt the CFG face on each 
N-tcrminel domain that could mcdiatc ell-ccl1 homotypic adhesion, 
Such arrays of chains would form a stronger bond between cells than 
single-chain CEA homotypic adhesion. 
One of the functions of CEA is to mediate cell-to-cell 
association via homotypic adhesion [39]. This interac- 
tion may involve the first one or two N-terminal do- 
mains of CEA, as expected for a closely related cell 
surface adhesion molecule NCAM (neural cell adhesion 
molecule) [40]. These interactions are similar to cell-cell 
association mediated by two Ig superfamily proteins, 
CD2 and LFA-3. There is sotne evidence to suggest that 
the first N-terminal from CD2 and the first N-terminal 
domain front LFA-3 mediate most of the homotypic 
interaction and that this occurs on their CFG faces [141. 
This face is also the packing face for each VL and VH 
domain in Fab fragments. The implication is that a 
sticky patch has evolved on this Face of an Ig fold. For 
the N-terminal domain of CEA this is also the face that 
seems to be void of carbohydrate. Indeed if the CFG 
face of the first N-terminal domain of CEA contributes 
all or most of the binding interface for homotypic inter- 
action, then this face would be the prime candidate for 
mutational studies. 
In addition to the homotypic interactions discussed 
above, there also exists the possibility of homodimeriza- 
tion of CEA chains on the same cell (section 2.6;. For 
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a homodimerization model an analogy with antibody 
can once again bc taken. The two chains of the dimer 
could run parallel to each other with some carbohy- 
drates trapped between the dimer interface as found in 
Fc fragments [30]. If the top N-terminal domain was 
covered on its ABDE face by the homodimer interface, 
the CFG face would still be free for homotypic interac- 
tions between cells. Therefore, as shown in Fig, 6, if 
both homodimerization and homotypic interactions 
occur at the same time an extensive array of CEA inter- 
actions can build up between cells producing a stronger 
adhesion than just single-chain CEA homotypic interac- 
tions on their own. 
In our model the linkers between domains are a few 
residues horter than in Fab fragments (see Fig. 3). 
Therefore we tentatively suggest that the angles between 
domains are less acute and the packing tighter than in 
Fab fragments. Tighter packing between Ig folds with 
similar twist angles between domains as those predicted 
for CEA has been found between the first two N-termi- 
nal domains of CD4 and is postulated for the first two 
N-terminal domains of ICAM-I [28]. Thus the complete 
molecule is expected to be rod shaped, Fig. 5, with no 
obvious kink between any of the seven domains. An 
electron micrograph study of CEA [41] also iildicates a 
rod-shaped molecule. This contrasts with the cell sur- 
face proteins NCAM [40] and ICAM-I [28] which have 
been shown by electron micrograph studies to contain 
hinge regions. 
Residues uitable for site-directed mutagenesis stud- 
ies have been indicated on the sequence alignments (Fig. 
2j. it is intended that this model for CEA. particularly 
the question of precisely how the domains are packed 
together, can be refined as more site-directed mutagcne- 
sis experiments are performed. 
Arkrro~~,/~~~~salt~rtrs: We thauk Drs. Paul Driscoll, Jason Cyrtcr. lain 
Ctmpbcll and Alan Williams for a pre.rclcusc 01’ the coordinates n( 
CD2, and Sir Walter Bodmcr. Helga Durbin and Dr. Fritz Wrbi for 
hclprul discussions, 
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